Aura Biosciences, Inc.
AURA
$7.93
-$0.26-3.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.77% | -0.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.40% | -2.47% | |||
| Operating Income | 2.40% | 2.47% | |||
| Income Before Tax | 2.15% | 3.21% | |||
| Income Tax Expenses | -42.31% | -45.83% | |||
| Earnings from Continuing Operations | 2.19% | 3.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.19% | 3.29% | |||
| EBIT | 2.40% | 2.47% | |||
| EBITDA | 2.39% | 2.47% | |||
| EPS Basic | 3.89% | 14.90% | |||
| Normalized Basic EPS | 3.84% | 14.87% | |||
| EPS Diluted | 3.89% | 14.90% | |||
| Normalized Diluted EPS | 3.84% | 14.87% | |||
| Average Basic Shares Outstanding | 1.76% | 13.65% | |||
| Average Diluted Shares Outstanding | 1.76% | 13.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||